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Background: The purpose of this study was to identify the extent to which pediatric and adult cystic ﬁbrosis (CF) care teams implement best
practices in adherence assessment and counseling.
Methods: All US CF Foundation accredited programs were invited to participate in a web-based survey; 80% (92/115) of pediatric and 40% (38/95) of
adult centers participated. Health care providers reported on current approaches and barriers to implementing adherence promotion practices.
Results: 64% discussed adherence at every clinic visit while only 8% used an objective assessment of adherence. Most centers reported frequent
use of strategies to increase knowledge; behavioral and support strategies were used less regularly. Several barriers to adherence promotion were
reported.
Conclusions: Many opportunities exist for care teams to improve consistency in adherence practices and integrate a greater repertoire of effective
counseling strategies into clinic visits. Adherence promotion practices should be considered for quality improvement (QI) projects.
© 2014 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Adherence; Counseling; Education; Provider; Barriers1. Introduction
The lifespan for people with cystic fibrosis (CF) has markedly
improved and is attributable to the development of new treatments.
Unfortunately, these advances have resulted in a complex and
time-consuming home program of self-care making perfect
adherence an unreasonable expectation [1]. Indeed, objective
medication adherence estimates range from 48 to 63%, with⁎ Corresponding author at: Johns Hopkins Adherence Research Center (JHARC),
ivision of Pulmonary & Critical Care Medicine, 5501 Hopkins Bayview Circle,
HAAC 3B.37, Baltimore, MD 21224, USA. Tel.: +1 410 550 7755; fax: +1 410
50 2612.
E-mail addresses: kriekert@jhmi.edu (K.A. Riekert), meakin1@jhmi.edu
.N. Eakin), abilder1@jhmi.edu (A. Bilderback), aridge@jhmi.edu
.K. Ridge), bmarshall@cff.org (B.C. Marshall).D
J
5
(M
(Ahttp://dx.doi.org/10.1016/j.jcf.2014.10.003
1569-1993© 2014 European Cystic Fibrosis Society. Published by Elsevier B.V. Anonadherence prevalent across the lifespan and associated with
poor health outcomes [2,3]. Moreover, CF physicians identify
patient nonadherence as a common barrier to providing guideline-
based care [4]. Therefore, supporting adherence is an important
role for healthcare providers to ensure people with CF fully
benefit from available therapies [5].
Healthcare provider–patient relationship factors such as
communication, support, trust, and inclusion in decision-making
are associated with better adherence in many diseases [6–8].
Among adults with CF, a commonly identified facilitator of
adherence is attending clinic visits in part due to the support
they receive from their care team [9]. Despite the importance of
provider–patient relationships in improving adherence, many
healthcare providers feel uncomfortable or ill-equipped to
provide behavioral counseling [10]. Healthcare providers also
cite practical barriers to providing adherence counseling suchll rights reserved.
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[11].
Extrapolating from communication research [12], one can posit
that adherence will be maximizedwhen there is consistency in how
providers handle nonadherence, ongoing assessment of adherence,
and the provision of quality, evidence-based counseling. Consis-
tency ensures the patient receives a clear and congruent message
about the importance of adherence from all care team members.
Ongoing Assessment includes the systematic use of objective
measures to reliably identify nonadherence. Quality Counseling
employs empirically validated educational, behavioral, and support
strategies to promote improved adherence. Understanding current
practices is critical to developing new, effective, and sustainable
clinic-based programs to support adherence promotion [13].
Clinics are unlikely to adopt strategies, no matter how efficacious,
if the strategies are not perceived as feasible to implement.
Therefore, the goal of this study was to survey CF care centers for
perceptions of adherence practices in the areas of consistency,
assessment approaches, and counseling strategies used. We also
aimed to elicit perceived barriers to adherence promotion in order
to identify areas of strength and opportunities for intervention.
We examined these variables overall, and by pediatric and adult
centers, to determine if pediatric and adult providers use different
strategies.
2 . Methods
2.1 . Procedures
All United States CF Foundation accredited pediatric and
adult care center directors and nurse coordinators were emailed an
invitation from the CF Foundation Director of Patient Resources
and Vice President for Clinical Affairs asking the center to par-
ticipate in a web-based survey on adherence practices. Each center
was asked to submit one survey with the recommendation that it be
completed by the nurse coordinator using feedback from the center
director and care team. Five email reminders were sent and the
surveywas available for onemonth. The JohnsHopkins University
Institutional ReviewBoard approved all study procedures. Portions
of these data were presented at the North American Cystic Fibrosis
Conference Orlando FL October 23–25, 2008 [14].
2.2 . Survey
The survey included the respondent's demographic character-
istics and estimates of the average total time allocated for a regular
quarterly clinic visit and the amount of time spent counseling about
adherence during these visits. Proportion of time allocated
to adherence was calculated by creating a ratio with the number
of minutes spent on adherence counseling as the numerator and
the total number of minutes for a regular quarterly visit as
the denominator. Items that assessed consistency of adherence
discussions, assessment approach, counseling practices, and
barriers were adapted from Golin et al. [11]. To keep the survey
brief and because practice may vary by different treatment
expectations, all survey questions were specific to medication
adherence.2.2.1 . Consistency
Respondents were asked to select one of four statements that
best matched their center's practice for discussing adherence
(“Medication adherence is discussed with the patient/parent only
when there is a concern about declining health”, “If a patient's
health is fine, medication adherence is formally discussed only
at the annual visit”, “Medication adherence is discussed with
every patient/parent at every clinic visit regardless of his/her
health status”, or “There is no consistent practice for discussing
adherence with a patient/parent”). Respondents also answered
a single item (“Our care center has a consistent approach or
philosophy for intervening when we identify a patient/parent
who is nonadherent”) on a 5-point Likert scale, ranging from
strongly agree to strongly disagree.
2.2.2 . Assessment approach
Respondents indicated how often (“never”, “rarely”, “some-
times”, “most of the time”, or “all of the time”) they used various
assessment strategies listed in Fig. 1 to identify medication
nonadherence.
2.2.3 . Counseling practices
Respondents rated how often they used common counseling
strategies to promote patient medication adherence on a 4-point
Likert scale (“never”, “sometimes”, “most of the time”, or “all
of the time”; see Table 1 for items).
2.2.4 . Barriers
Previously identified barriers to adherence promotion were
queried on a 5-point Likert scale, ranging from 4 = strongly agree
to 0 = strongly disagree (see Table 2 for items). Respondents were
also asked whether they would be interested in learning an
adherence program that took 5 min or 15 min to implement to
assess the impact of clinic-based time constraints on adherence
promotion.
2.3 . Statistical analyses
When multiple surveys were received from a single center, one
survey was selected using the following prioritization: nurse
coordinator, center director, physician, and other team member.
Descriptive frequencies of provider characteristics were generated
using means and proportions as appropriate. Statistical compar-
isons between groups were made using 2-tailed t-tests and chi-
square tests as appropriate. STATA 13.1 (StataCorp LP, College
Station, TX) was used for all statistical analyses. P-values b 0.05
were considered statistically significant.
3. Results
One hundred fifteen pediatric and ninety-five adult CF care
centers were invited to participate; at least one team member
from 80% (n = 92) of pediatric care centers and 40% (n = 38)
of adult care centers submitted a survey. Respondents had
varying care team roles, including nurse coordinators (59%),
physicians (19%), and center directors (11%). Most participants
were female (62%) and had worked in CF for more than 5 years
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Fig. 1. Percent of CF care centers endorsing each assessment strategy.
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to be 60 (IQR 30, 60) minutes and they dedicated a median of
17% (IQR 13%, 33%) of visit time to addressing adherence
with no differences between pediatric and adult centers. Almost all
healthcare providers agreed or strongly agreed that nonadherence is
a major contributor to CF morbidity and mortality (91% and 86%
respectively) again with no differences between pediatric and adult
centers.
3.1. Consistency
Among respondents, 65% said adherence was discussed at
every visit, while 23% reported no standard practice for discussingTable 1
Percent of CF centers reporting performance of adherence counseling activities mos
Educational strategies
Ask if patient/parent has questions or concerns about their treatment
Review the dosing schedule for each prescribed medicine
Discuss consequences of nonadherence
Provide written dosing instructions
Ask the patient/parent to repeat or rehearse dosing instructions
Explain what to do if a dose is missed
Behavioral strategies
Include the patient/parent in decisions about changes to the regimen
Ask about barriers that make it hard to follow treatment regimen
Help patient/parent plan dosing times to fit his/her daily routine
Suggest strategies to remember when to take medication
Encourage the use of reminder systems (e.g., diary, pill box)
Social support and encouragement
Ask a nonadherent patient/parent to return to clinic sooner
Ask about availability of social support (e.g., family, friends) to encourage adheren
Telephone or email a patient/parent to follow up on medication use or side effectsadherence and the remainder (12%) discussed adherence only with
a decline in the patient's health or at the annual visit. Only 48% of
the participants agreed or strongly agreed that their center employs
a consistent approach or philosophy for intervening when a patient
is nonadherent, while 28% disagreed or strongly disagreed. There
were no differences between pediatric and adult centers.
3.2. Assessment approach
Centers rarely used an objective assessment of adherence
(e.g., pharmacy refill data; Fig. 1), with the vast majority relying
on clinical impression or direct questions. Several respondents
indicated that they assumed adherence was fine if pulmonaryt or all the time.
Overall
N = 125
N (%)
Adult
n = 36
N (%)
Pediatric
n = 89
N (%)
p
109 (88) 28 (78) 81 (92) 0.027
108 (86) 29 (81) 79 (89) 0.225
98 (78) 28 (78) 70 (79) 0.914
86 (69) 19 (53) 67 (75) 0.014
54 (44) 10 (28) 44 (51) 0.020
42 (34) 11 (31) 31 (35) 0.618
109 (87) 31 (86) 78 (88) 0.817
91 (73) 23 (64) 68 (76) 0.154
68 (55) 17 (47) 51 (58) 0.276
64 (51) 17 (47) 47 (53) 0.571
52 (42) 12 (34) 40 (45) 0.279
99 (80) 27 (75) 72 (82) 0.390
ce 72 (58) 20 (57) 52 (58) 0.896
25 (20) 12 (33) 13 (15) 0.018
Table 2
Mean (SD) and percent of respondents who agree or strongly agree (A/SA) with each barrier to adherence counseling.
Barrier to adherence counseling Overall
N = 121
Adult
N = 35
Pediatric
N = 86
M (SD) N (%)
A/SA
M (SD) n (%)
A/SA
M (SD) n (%)
A/SA
Adherence counseling is a good use of my time 3.1 (0.6) 104 (87) 3.1 (0.6) 31 (89) 3.1 (0.6) 73 (86)
I am adequately trained to provide adherence counseling 2.8 (0.9) 84 (69) 2.9 (0.9) 26 (74) 2.8 (0.9) 58 (67)
I have the skills necessary to provide quality adherence counseling 2.8 (0.8) 81 (68) 2.9 (0.8) 26 (74) 2.7 (0.8) 55 (65)
What the CF health care team says to a patient/parent significantly affects adherence 2.7 (0.7) 79 (65) 2.7 (0.9) 22 (63) 2.7 (0.7) 57 (66)
Adherence counseling done during clinic time is effective in increasing patient/parent adherence 2.7 (0.7) 72 (60) 2.7 (0.7) 22 (63) 2.7 (0.7) 50 (58)
There is adequate time during a clinic visit to provide adherence counseling 2.5 (1.0) 77 (64) 2.8 (0.9) 25 (71) 2.4 (1.1) 52 (60)
Our team has sufficient access to experts who can counsel patients/parents about
adherence (e.g., psychologists, psychiatrists, social workers, pharmacists)
2.3 (1.2) 61 (50) 2.3 (1.2) 18 (51) 2.3 (1.1) 43 (50)
There is enough clinic/office space to provide adherence counseling 2.0 (1.2) 53 (44) 2.5 (1.1) 23 (66) 1.8 (1.2) a 30 (35 a)
Reimbursement is adequate for providing adherence counseling 1.3 (1.0) 15 (12) 1.7 (0.9) 6 (17) 1.1 (1.0) a 9 (10)
a p b 0.01.
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between pediatric and adult centers.
3.3 . Counseling strategies
3.3.1 . Educational
Most strategies to increase patient/parent knowledge were
highly endorsed (Table 1). Fewer centers regularly used more time
consuming yet effective educational strategies such as providing
written dosing instructions (69%) and asking a patient or parent to
repeat dosing instructions (44%); moreover, the adult group was
significantly less likely to report use of these two strategies
compared to the pediatric group (p b .05). Only a third of centers
provided guidance on what patients should do if they realize they
missed a treatment dose.
3.3.2. Behavioral
There was high endorsement for including patients and families
in decisions about regimen changes and asking about treatment
barriers. It is notable, however, that approximately half of centers
or fewer regularly used effective behavioral strategies to support
adherence including helping patients plan dosing time to fit
their daily routine (55%), suggesting strategies to remember to take
medicine (51%), and encouraging the use of reminder systems
(42%). No differences were found between pediatric and adult
centers in the use of behavioral strategies.
3.3.3. Support
Respondents regularly requested that patients return to clinic
sooner (80%) when adherence concerns existed. However, little
more than half of respondents asked about available social
support and few respondents called or emailed a patient after a
visit to follow up on adherence problems. Interestingly, adult
centers were more likely to telephone or email patients after
clinic visits than those from pediatric centers (p b .05).
3.4. Barriers to providing adherence counseling
Approximately two-thirds of respondents agreed that they had
the necessary training and skills to provide counseling although40% were not convinced that their counseling was efficacious
(Table 2). Similarly two-thirds of the respondent agreed that
there was enough time during clinic visits to provide adherence
counseling while fewer felt that sufficient clinic space was avail-
able to them and almost none agreed that they were adequately
reimbursed for adherence promotion. On average, respondents
from pediatric centers were less likely to agree that they had
adequate space and reimbursement for adherence counseling than
adult centers (p b 0.01). Only half the centers agreed that they had
access to professionals with expertise in adherence counseling.
Finally, interest in learning an adherence intervention dropped
considerably from 64% being extremely interested to 31%
(p b .0001) when the hypothetical time commitment for counsel-
ing increased from 5 to 15 min per patient. Table 3 provides
responses from a comment section that illustrates these barriers. No
new barriers were identified from evaluation of responses to the
open-ended question.
4 . Discussion
In other chronic illnesses, the patient–provider relationship has
been shown to be associated with improved adherence and there
are several behaviors that a healthcare provider can use to promote
adherence [7,15,16]. In CF, adults with CF indicate that clinic visits
support their attempts to adhere to their regimen [9]. The
findings from this investigation of US CF care centers' medication
adherence promotion practices suggests that, although almost 20%
of the visit is perceived to be dedicated to adherence promotion,
there is high variability in adherence practices across US CF
Care Centers and many potential opportunities for intervening are
missed. An encouraging finding was that there was near universal
agreement among respondents that regimen adherence is essential
for increasing lifespan and decreasing morbidity among patients
with CF. Remarkably, there were few differences between
pediatric and adult centers.
The first step in addressing nonadherence is identifying it;
however, 35% of centers do not assess medication adherence at
every visit. Furthermore, the use of reliable and valid assessment
approaches was rare. CF providers were much more likely to use
subjective approaches such as questioning patients and clinician
Table 3
Participant comments regarding challenges of providing adherence counseling.
Perceived
ineffectiveness of
adherence
counseling
I spend considerable time trying to motivate and cajole nonadherent patients to get with the program. I have to say that I don't
view this as on the whole terribly effective. I still do it, because it is my responsibility … I have had a few who, perhaps in a
teachable moment or when they had reached the end of their rope, began to do their treatments and then felt better, but many
times it seems as if I'm talking to a brick wall.
We go over medications with every patient at every encounter. I personally spend an enormous amount of time dealing with compliance
issues. I'm not convinced that this results in improved medication and treatment adherence.
Addressing adherence to an individual's treatment regimen is crucial although I do not feel we are adequately trained.
Time burden
of providing
adherence
counseling
… I also think that a big part of the burden in discussing lack of adherence falls on the physician so having a quick/effective way of doing this
would help.
I believe that adherence is important and improving adherence is an excellent way to improve [quality of life] and mortality. I would welcome
suggestions that would help us improve adherence; however, I am very concerned about how I will find the time for the team members to do a
more formal adherence intervention.
I am interested in a program with the understanding that 15 additional minutes in an already very busy clinic is a large amount of time
(especially with all of the other very complex patient related issues, clinical trials, and paperwork already required of the staff).
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records. Patient reports and healthcare provider estimates overes-
timate true adherence and providers are often no better than chance
at identifying nonadherence [15,17]. Inaccurate assessments
result in missed opportunities to provide patients and families
with needed counseling and support. With the increasing avail-
ability of pharmacy records through e-prescribing and electronic
monitors, such as the i-Neb [18,19], that provide data on patterns
of medication adherence, it may soon become more feasible to
regularly use objective measures [5]. These methods, however,
provide copious amounts of data that must be reduced into
metrics that are not only meaningful to clinicians and patients but
may be easily integrated into clinic flow. For example, results
embedded into electronic medical records will be more practical
and sustainable than requiring clinicians to access outside portals.
Future research is needed to validate these objective measures as
well as identify and address the challenges to using them in
clinical practice. Similarly, research is needed to identify the best
way to display the data for providers and patients in a way that not
only supports understanding but also has the greatest impact
on behavior. Within and across countries there are differing
philosophies about the ethics of accessing and using of pharmacy
records and electronic monitoring with an overarching concern
that the data will be used punitively to “catch” patients lying
about their behavior and/or deny services. Care needs to be taken
to minimize negative consequences, whichmay include educating
training care teams, healthcare systems, payers, etc. about the risks
and benefits of using this data.
It is concerning that almost 20% of centers assume that
adherence is sufficient if lung function is stable or only discuss
adherence if the patient is sick. Failing to address nonadherence
before health problems arise leaves the patient to assume that they
are “adherent enough” thereby reinforcing subpar behavioral
habits that may be challenging to undo. Similarly, waiting until a
person is having health problems may lead to a confrontational,
rather than collaborative, interaction leaving the person with
CF feeling judged, defensive, and less willing to engage in
conversations about changing their behavior. Regardless of the
patient's level of adherence, it is essential for CF care teams
to approach the conversation in a collaborative and empathic
manner to maintain a positive therapeutic relationship. Forexample, the use of patient-centered strategies, such as shared
decision making and motivational interviewing, have been
shown to be effective in improving adherence in other chronic
illnesses and should be study specifically in CF [12,20].
Even when adherence was identified, only half the respondents
felt that there was a consistent approach to intervening across care
team members. Continuity and consistency are highly valued
by parents of children with CF [21]. CF centers have become
increasingly multidisciplinary which may lead to “too many
cooks in the kitchen”. Patients and families can easily become
overwhelmed with the volume of recommendations and may
receive mixed messages about the importance of adhering to
various aspects of the regimen or how to overcome adherence
barriers, leaving them on their own to decide how to best
integrate their complex regimen into their daily lives.
Educational strategies were regularly provided to promote
adherence; unfortunately, a substantial literature has demon-
strated that improving knowledge is necessary but not sufficient
[22]. Strategies such as providing written treatment plans
and using a “Tell Me Back” approach have been shown to be
effective for adherence promotion in other chronic illnesses
[23,24] but were used by CF providers less often. Interestingly,
adult centers were less likely to use these strategies compared to
pediatric centers, perhaps reflecting an assumption that adults
with CF already have the necessary knowledge. A promising
finding is that centers regularly engaged in shared-decision
making about the regimen, asked about adherence barriers and,
if concerned about adherence, asked patients to return to clinic
sooner. However, many providers did not proceed to the next
level by providing specific advice or problem-solving on how to
remember to do therapies, integrate the regimen into a busy life,
or access social supports. These approaches have been shown to
be important in promoting adherence in other chronic illnesses.
Indeed, meta-analyses of adherence interventions suggest the
most efficacious interventions are complex and multidimensional
[25]. In a qualitative study about perceived value of CF care, the
most common reason patients found CF visits unhelpful was they
were too repetitive and patients did not learn anything new [26].
In the same study, helpfulness in providing knowledge and skills
was associated with higher ratings of quality of care by parents
and patients. Personalizing and tailoring adherence promotion
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necessary to ensure that patients receive the appropriate advice
and counseling to perceive clinic visits as worthwhile. These types
of interventions should be develop and tested to evaluate their
efficacy for people with CF.
As might be expected, inadequate time, clinic space, reim-
bursement, and access to adherence experts were common barriers
to providing adherence counseling, as were concerns about
whether the care team was effective in changing behavior.
CF providers may be interested and ready to engage in training
opportunities to improve their counseling skills, particularly if there
is evidence that their efforts will improve adherence and health
outcomes. How much time an intervention takes will clearly be
a challenge given the drop in enthusiasm for a 15-min
hypothetical intervention compared to one lasting 5 min. There-
fore, from a sustainability perspective, interventions must be brief
and easily integrated into the clinic setting. Unfortunately as noted
above, the most efficacious interventions are complex and time
consuming. Thus, in clinic settings as they are currently organized,
there will be constant tension between efficacy and practicality.
Alternative models for providing supplemental adherence support
outside the traditional clinic visit therefore must be developed and
evaluated with particular attention given to coordination and
integration with the existing CF care delivery model.
The results of this survey must be interpreted within its
limitations. This study included only one representative of the
center's care team whose perceptions, beliefs, and behaviors
may not fully reflect the center's typical approach to adherence
promotion. Furthermore, actual frequency and quality of counsel-
ing delivered cannot be objectively determined. Despite a high
response rate (62%), care centers who responded to the surveymay
not be representative of all care centers in the United States; hence,
these findings may not be generalized to all centers, particularly for
adult centers, which had a lower response rate, or centers outside
the US. The lower response rate among adult providers relative to
pediatric providers has been shown in previous research [4,28,29].
Centers choosing to participate likely reflect centers more aware
and engaged in adherence practices with our results therefore
reflecting a best-case scenario. Additionally, the association
between care centers' adherence practices and patients' actual
adherence or health outcomes was not measured; therefore, we
cannot conclude that more frequent use of these behaviors results
in better outcomes. Still, the adherence practices included in the
survey do have a strong empirical basis as strategies to improve
adherence [12,25] and adherence is associated with health
outcomes in CF [2,3]. Finally, our questions focused exclusively
on medication adherence and did not address airway clearance or
nutritional adherence, which are also important components of the
regimen. While it would have been informative to know if
adherence practices differ by regimen tasks, it was decided that the
resulting increased survey length would negatively impact the
response rate. Future research should examine how centers address
nonadherence to airway clearance, nutrition, and other aspects of
the regimen.
Despite these limitations, these findings suggest many oppor-
tunities to improve the provision of evidence-based adherence
promotion at CF care centers some of which involve minorchanges to how a clinic session is organized and others that may
necessitate larger system changes or further empirical evaluation.
Given the CF community's commitment to quality improvement
(QI) [27], it is suggested that centers use QI methodology to
develop projects to ensure that adherence is assessed and addressed
at each clinic visit, written treatment plans are provided, problem-
solving is done with patients to overcome daily treatment
barriers, etc. Few studies have evaluated the efficacy of adherence
promotion interventions in CF populations and rarely are these
interventions integrated with regular CF services. There is great
opportunity to discover not only what strategies are most effective,
but also what resources are needed to incorporate them into
standard clinical care. Much as once-size-fits-all intervention will
not improve patient adherence, a single, best approach does not
exist to help care centers optimize their approach to intervening
with their patients.Acknowledgment
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